Pandemic Makes OTC Access To Daily Oral Contraceptives More Critical, Experts Tell FDA

Nearly 120 researchers, clinicians and advocacy groups have signed a letter to be sent in late August urging FDA to prioritize completion of a review process to make oral contraceptives available OTC.

The coronavirus pandemic has heightened the already critical need in the US for OTC access to daily oral contraceptives, reproductive health researchers, clinicians and advocacy groups contend in urging the Food and Drug Administration to prioritize completing a review on making the drugs available OTC.

The letter, signed by nearly 120 researchers, clinicians and advocacy representatives, notes a 2020 Guttmacher Institute survey found one...